These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28591733)

  • 1. ABCG2 downregulation in glioma stem cells enhances the therapeutic efficacy of demethoxycurcumin.
    Chen L; Shi L; Wang W; Zhou Y
    Oncotarget; 2017 Jun; 8(26):43237-43247. PubMed ID: 28591733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demethoxycurcumin was prior to temozolomide on inhibiting proliferation and induced apoptosis of glioblastoma stem cells.
    Shi L; Fei X; Wang Z
    Tumour Biol; 2015 Sep; 36(9):7107-19. PubMed ID: 25877753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
    Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
    Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-Dose DMC Significantly Enhances the Effect of TMZ on Glioma Cells by Targeting Multiple Signaling Pathways Both In Vivo and In Vitro.
    Shi L; Sun G
    Neuromolecular Med; 2015 Dec; 17(4):431-42. PubMed ID: 26458914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma.
    Singer E; Judkins J; Salomonis N; Matlaf L; Soteropoulos P; McAllister S; Soroceanu L
    Cell Death Dis; 2015 Jan; 6(1):e1601. PubMed ID: 25590811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-neoplastic activity of low-dose endothelial-monocyte activating polypeptide-II results from defective autophagy and G2/M arrest mediated by PI3K/Akt/FoxO1 axis in human glioblastoma stem cells.
    Liu J; Liu L; Xue Y; Meng F; Li S; Wang P; Liu Y
    Biochem Pharmacol; 2014 Jun; 89(4):477-89. PubMed ID: 24792437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-145 inhibits migration and invasion of glioma stem cells by targeting ABCG2.
    Shi L; Wang Z; Sun G; Wan Y; Guo J; Fu X
    Neuromolecular Med; 2014 Jun; 16(2):517-28. PubMed ID: 24777293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioma stem-like cells are less susceptible than glioma cells to sonodynamic therapy with photofrin.
    Xu ZY; Li XQ; Chen S; Cheng Y; Deng JM; Wang ZG
    Technol Cancer Res Treat; 2012 Dec; 11(6):615-23. PubMed ID: 22775340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ABCG2 transporter is a key molecular determinant of the efficacy of sonodynamic therapy with Photofrin in glioma stem-like cells.
    Xu ZY; Wang K; Li XQ; Chen S; Deng JM; Cheng Y; Wang ZG
    Ultrasonics; 2013 Jan; 53(1):232-8. PubMed ID: 22771084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin decreases malignant characteristics of glioblastoma stem cells via induction of reactive oxygen species.
    Gersey ZC; Rodriguez GA; Barbarite E; Sanchez A; Walters WM; Ohaeto KC; Komotar RJ; Graham RM
    BMC Cancer; 2017 Feb; 17(1):99. PubMed ID: 28160777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of ABCG2 protein inhibits migration and invasion in U251 glioma stem cells.
    Gong W; Wang Z; Wan Y; Shi L; Zhou Y
    Neuroreport; 2014 May; 25(8):625-32. PubMed ID: 24781949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
    Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H
    Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demethoxycurcumin analogue DMC-BH inhibits orthotopic growth of glioma stem cells by targeting JNK/ERK signaling.
    Shi L; Sun G; Zhu H
    Aging (Albany NY); 2020 Jul; 12(14):14718-14735. PubMed ID: 32710727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting of glioma stem-like cells with a parthenolide derivative ACT001 through inhibition of AEBP1/PI3K/AKT signaling.
    Hou Y; Sun B; Liu W; Yu B; Shi Q; Luo F; Bai Y; Feng H
    Theranostics; 2021; 11(2):555-566. PubMed ID: 33391492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suberoylanilide hydroxamic acid represses glioma stem-like cells.
    Hsu CC; Chang WC; Hsu TI; Liu JJ; Yeh SH; Wang JY; Liou JP; Ko CY; Chang KY; Chuang JY
    J Biomed Sci; 2016 Nov; 23(1):81. PubMed ID: 27863490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of ABCG2 expression in glioblastoma cancer stem cells with miRNA-328 may decrease their chemoresistance.
    Li WQ; Li YM; Tao BB; Lu YC; Hu GH; Liu HM; He J; Xu Y; Yu HY
    Med Sci Monit; 2010 Oct; 16(10):HY27-30. PubMed ID: 20885358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A curcumin derivative hydrazinobenzoylcurcumin suppresses stem-like features of glioblastoma cells by targeting Ca
    Shin HJ; Lee S; Jung HJ
    J Cell Biochem; 2019 Apr; 120(4):6741-6752. PubMed ID: 30390339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demethoxycurcumin Suppresses Human Brain Glioblastoma Multiforme GBM 8401 Cell Xenograft Tumor in Nude Mice
    Huang YP; Ma YS; Kuo CL; Liao CL; Chen PY; Peng SF; Hsu FT; Lai KC
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DMC is not better than TMZ on intracranial anti-glioma effects.
    Shi L; Sun G
    J Cell Biochem; 2018 Jul; 119(7):6057-6064. PubMed ID: 29575236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA 145 enhances chemosensitivity of glioblastoma stem cells to demethoxycurcumin.
    Qian C; Wang B; Zou Y; Zhang Y; Hu X; Sun W; Xiao H; Liu H; Shi L
    Cancer Manag Res; 2019; 11():6829-6840. PubMed ID: 31440081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.